Nifty
Sensex
:
:
24868.60
81101.32
95.45 (0.39%)
314.02 (0.39%)

Pharmaceuticals & Drugs

Rating :
73/99

BSE: 543349 | NSE: ACUTAAS

1503.90
09-Sep-2025
  • Open
  • High
  • Low
  • Previous Close
  •  1465
  •  1530.3
  •  1464
  •  1469.70
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  589269
  •  885123718
  •  1530.3
  •  704.1

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 12,317.18
  • 63.57
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 12,076.44
  • 0.05%
  • 8.88

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 32.66%
  • 1.62%
  • 23.27%
  • FII
  • DII
  • Others
  • 16.94%
  • 20.96%
  • 4.55%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 20.68
  • 24.21
  • 17.75

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 29.00
  • 23.69
  • 13.61

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 28.77
  • 24.06
  • 23.98

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 61.63

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 6.69

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 37.40

Earnings Forecasts:

(Updated: 08-09-2025)
Description
2024
2025
2026
2027
Adj EPS
9.9
27.21
37.99
41.83
P/E Ratio
148.45
54.01
38.69
35.14
Revenue
1006.88
1281.61
1591.14
1913.96
EBITDA
232.07
310.25
396.62
498.32
Net Income
158.71
215.92
278.96
344.55
ROA
12
12.47
13.56
17.46
P/B Ratio
18.38
7.68
5.70
5.43
ROE
16
15.29
16.91
18.43
FCFF
122.94
36.09
99.01
178.33
FCFF Yield
1.25
0.37
1.01
1.82
Net Debt
-235.99
-271.77
-347.73
-552.9
BVPS
79.98
191.4
257.73
270.9

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
207.24
176.67
17.30%
308.48
224.96
37.13%
274.99
166.44
65.22%
246.73
172.36
43.15%
Expenses
156.33
147.15
6.24%
223.53
181.80
22.95%
206.32
139.94
47.43%
197.80
147.54
34.07%
EBITDA
50.91
29.52
72.46%
84.96
43.16
96.85%
68.67
26.51
159.03%
48.93
24.81
97.22%
EBIDTM
24.57%
16.71%
27.54%
19.19%
24.97%
15.93%
19.83%
14.40%
Other Income
15.94
1.04
1,432.69%
5.78
1.34
331.34%
1.67
3.49
-52.15%
8.44
1.50
462.67%
Interest
0.64
4.43
-85.55%
0.60
2.07
-71.01%
0.69
2.54
-72.83%
0.50
0.82
-39.02%
Depreciation
8.13
6.18
31.55%
7.30
4.90
48.98%
6.32
3.76
68.09%
6.83
3.69
85.09%
PBT
58.08
19.96
190.98%
82.84
37.20
122.69%
63.33
23.70
167.22%
50.04
-9.94
-
Tax
14.07
5.26
167.49%
20.12
11.53
74.50%
17.89
5.89
203.74%
12.47
7.08
76.13%
PAT
44.01
14.69
199.59%
62.72
25.68
144.24%
45.45
17.81
155.19%
37.57
-17.02
-
PATM
21.24%
8.31%
20.33%
11.41%
16.53%
10.70%
15.23%
-9.87%
EPS
5.41
1.70
218.24%
3.82
3.41
12.02%
5.49
2.27
141.85%
4.56
-2.56
-

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 18
Mar 17
Mar 16
Net Sales
1,037.44
1,006.88
717.47
616.73
520.13
340.61
239.64
188.22
160.26
153.70
Net Sales Growth
40.11%
40.34%
16.33%
18.57%
52.71%
42.13%
27.32%
17.45%
4.27%
 
Cost Of Goods Sold
546.74
552.18
411.69
330.89
272.83
179.68
128.91
112.95
95.00
91.50
Gross Profit
490.70
454.69
305.79
285.84
247.30
160.92
110.73
75.27
65.27
62.21
GP Margin
47.30%
45.16%
42.62%
46.35%
47.55%
47.24%
46.21%
39.99%
40.73%
40.47%
Total Expenditure
783.98
774.80
588.98
494.13
414.96
260.45
198.63
157.70
137.13
135.51
Power & Fuel Cost
-
30.12
25.82
22.28
21.40
5.26
4.54
1.27
1.00
1.26
% Of Sales
-
2.99%
3.60%
3.61%
4.11%
1.54%
1.89%
0.67%
0.62%
0.82%
Employee Cost
-
83.66
63.11
48.84
41.37
21.01
17.81
9.89
7.38
7.02
% Of Sales
-
8.31%
8.80%
7.92%
7.95%
6.17%
7.43%
5.25%
4.61%
4.57%
Manufacturing Exp.
-
51.77
47.35
46.98
49.66
41.32
34.60
19.87
15.42
14.41
% Of Sales
-
5.14%
6.60%
7.62%
9.55%
12.13%
14.44%
10.56%
9.62%
9.38%
General & Admin Exp.
-
19.23
12.97
9.93
7.30
4.46
4.72
8.59
13.68
15.24
% Of Sales
-
1.91%
1.81%
1.61%
1.40%
1.31%
1.97%
4.56%
8.54%
9.92%
Selling & Distn. Exp.
-
29.63
19.88
26.49
19.92
7.01
5.79
3.97
3.92
5.36
% Of Sales
-
2.94%
2.77%
4.30%
3.83%
2.06%
2.42%
2.11%
2.45%
3.49%
Miscellaneous Exp.
-
8.22
8.15
8.71
2.49
1.72
2.26
1.16
0.74
0.73
% Of Sales
-
0.82%
1.14%
1.41%
0.48%
0.50%
0.94%
0.62%
0.46%
0.47%
EBITDA
253.47
232.08
128.49
122.60
105.17
80.16
41.01
30.52
23.13
18.19
EBITDA Margin
24.43%
23.05%
17.91%
19.88%
20.22%
23.53%
17.11%
16.22%
14.43%
11.83%
Other Income
31.83
16.93
7.49
4.32
2.76
1.38
2.84
2.96
0.21
2.87
Interest
2.43
6.22
5.94
2.41
6.41
5.62
5.59
3.23
3.30
2.56
Depreciation
28.58
26.62
16.06
12.34
10.08
4.19
3.52
1.91
1.37
0.80
PBT
254.29
216.16
113.99
112.17
91.45
71.73
34.75
28.35
18.68
17.70
Tax
64.55
55.75
33.19
28.88
19.50
17.73
7.28
9.85
6.63
5.04
Tax Rate
25.38%
25.79%
40.52%
25.75%
21.32%
24.72%
20.95%
34.74%
35.49%
28.47%
PAT
189.75
158.72
42.78
83.29
71.95
54.00
27.47
18.50
12.05
12.66
PAT before Minority Interest
189.07
160.42
48.71
83.29
71.95
54.00
27.47
18.50
12.05
12.66
Minority Interest
-0.68
-1.70
-5.93
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
18.29%
15.76%
5.96%
13.51%
13.83%
15.85%
11.46%
9.83%
7.52%
8.24%
PAT Growth
361.01%
271.01%
-48.64%
15.76%
33.24%
96.58%
48.49%
53.53%
-4.82%
 
EPS
23.17
19.38
5.22
10.17
8.79
6.59
3.35
2.26
1.47
1.55

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 18
Mar 17
Mar 16
Shareholder's Funds
1,309.63
674.00
593.96
522.27
166.93
111.81
57.68
38.99
27.42
Share Capital
40.93
36.88
36.44
36.44
31.50
10.50
1.50
1.50
1.50
Total Reserves
1,268.59
634.81
557.52
485.84
135.43
101.31
56.18
37.49
25.92
Non-Current Liabilities
26.93
127.98
10.13
7.29
80.29
25.46
32.73
15.09
15.21
Secured Loans
0.00
113.64
0.63
0.59
71.82
12.59
28.10
14.03
13.94
Unsecured Loans
0.00
0.00
0.00
0.00
0.82
7.31
3.68
0.47
2.05
Long Term Provisions
2.55
1.32
0.68
0.44
4.37
2.44
0.98
0.63
0.37
Current Liabilities
202.25
285.17
162.85
129.32
166.04
94.61
65.00
54.82
48.60
Trade Payables
156.05
134.61
142.05
118.42
84.78
51.45
47.76
38.43
28.42
Other Current Liabilities
13.48
64.78
6.64
4.88
34.62
8.84
3.36
4.99
5.07
Short Term Borrowings
8.18
72.59
2.77
0.00
44.53
33.92
9.48
9.06
11.49
Short Term Provisions
24.54
13.20
11.39
6.02
2.12
0.41
4.40
2.34
3.63
Total Liabilities
1,549.26
1,095.91
766.94
658.88
413.26
231.88
155.41
108.90
91.23
Net Block
570.39
427.16
258.95
204.53
186.31
85.19
31.54
27.76
18.48
Gross Block
651.64
481.95
297.69
231.14
202.83
97.78
41.13
35.45
24.81
Accumulated Depreciation
81.25
54.79
38.74
26.60
16.52
12.59
9.60
7.69
6.32
Non Current Assets
757.63
602.60
309.81
229.31
190.83
110.86
66.45
42.30
24.90
Capital Work in Progress
130.28
125.42
29.80
2.96
0.20
11.71
30.32
11.42
3.77
Non Current Investment
0.20
0.20
1.65
1.71
1.43
1.73
2.55
1.43
1.37
Long Term Loans & Adv.
55.88
48.59
17.20
14.23
1.65
2.68
0.76
0.54
0.48
Other Non Current Assets
0.88
1.23
2.21
5.87
1.25
9.55
1.28
1.15
0.80
Current Assets
791.64
493.30
457.13
429.57
216.23
121.04
87.19
66.48
66.17
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
179.94
156.73
119.17
112.17
60.36
52.34
27.39
19.72
19.64
Sundry Debtors
290.49
206.35
230.26
163.70
120.69
56.40
49.97
36.49
36.30
Cash & Bank
248.93
53.31
58.67
99.55
2.68
3.82
1.17
3.58
0.51
Other Current Assets
72.27
4.44
7.95
11.09
32.49
8.47
8.67
6.68
9.72
Short Term Loans & Adv.
69.20
72.47
41.08
43.05
20.76
8.31
8.54
6.29
9.48
Net Current Assets
589.39
208.13
294.28
300.25
50.19
26.42
22.19
11.66
17.57
Total Assets
1,549.27
1,095.90
766.94
658.88
413.26
231.90
155.41
108.90
91.24

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
118.34
125.17
65.53
-11.93
27.96
27.08
8.46
28.54
9.86
PBT
216.16
81.90
112.17
91.45
71.73
34.75
28.35
18.68
17.70
Adjustment
18.92
49.79
14.09
13.64
8.02
10.17
4.43
4.07
2.66
Changes in Working Capital
-70.01
17.82
-36.28
-94.21
-37.61
-9.44
-16.54
12.56
-7.53
Cash after chg. in Working capital
165.08
149.52
89.98
10.88
42.14
35.49
16.24
35.31
12.83
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-46.74
-24.35
-24.45
-22.81
-14.18
-8.41
-7.78
-6.78
-2.98
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-223.94
-365.39
-33.04
-120.72
-101.21
-23.94
-25.32
-18.61
-14.23
Net Fixed Assets
-170.91
-245.28
-83.19
-30.11
-90.85
-31.67
-21.20
-14.99
Net Investments
-2.07
-34.28
-0.05
-0.16
-5.35
-6.72
-5.77
-4.04
Others
-50.96
-85.83
50.20
-90.45
-5.01
14.45
1.65
0.42
Cash from Financing Activity
261.12
239.36
-12.25
140.26
72.11
0.19
14.62
-7.11
4.37
Net Cash Inflow / Outflow
155.52
-0.86
20.24
7.61
-1.14
3.33
-2.23
2.82
-0.01
Opening Cash & Equivalents
29.70
30.53
10.30
2.68
3.82
0.49
3.14
0.32
0.33
Closing Cash & Equivalent
185.22
29.70
30.53
10.30
2.68
3.82
0.90
3.14
0.32

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
79.98
91.06
163.01
143.34
17.01
106.49
372.75
259.14
181.71
ROA
12.13%
5.23%
11.68%
13.42%
16.74%
12.34%
13.99%
12.04%
13.87%
ROE
16.19%
7.70%
14.92%
21.07%
39.63%
28.31%
39.03%
36.44%
46.43%
ROCE
20.14%
11.81%
20.45%
23.85%
33.01%
26.25%
38.24%
35.91%
35.54%
Fixed Asset Turnover
1.78
1.84
2.33
2.40
2.27
2.54
4.92
5.32
6.20
Receivable days
90.06
111.06
116.58
99.79
94.89
100.90
83.83
82.89
86.20
Inventory Days
61.02
70.18
68.46
60.54
60.39
69.31
45.68
44.82
46.64
Payable days
96.06
122.64
143.66
135.92
138.36
169.65
99.64
97.78
86.73
Cash Conversion Cycle
55.02
58.60
41.38
24.41
16.92
0.56
29.87
29.93
46.11
Total Debt/Equity
0.01
0.32
0.01
0.00
0.85
0.53
0.78
0.68
1.09
Interest Cover
35.76
14.79
47.50
15.27
13.77
7.22
9.79
6.67
7.92

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.